Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study

Richa Verma; Preeti Yadav; Mayur Chudhari; Jayshree Patel; Dipak Umrigar

doi:10.5455/njppp.2022.12.03100202221042022

2024, Vol: 14, Issue: 4

14 / 4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Online Publishing Date:
02 / 05 / 2022

Natl J Physiol Pharm Pharmacol. 2022; 12(6): 817-822

doi: 10.5455/njppp.2022.12.03100202221042022

Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study

Richa Verma, Preeti Yadav, Mayur Chudhari, Jayshree Patel, Dipak Umrigar.

Abstract
Background: Acne vulgaris is common skin problem for adolescents and young adults. Topical clindamycin is an established treatment modality effective in mild-to-moderate acne. Dapsone has been used orally for the treatment of acne but used less due to its systemic side effects. Topical dapsone may offer new treatment option for acne vulgaris due to its dual anti-inflammatory and anti-microbial effect.

Aim and Objective: The aim of the study was to compare the efficacy of 1% clindamycin gel with 5% dapsone gel in the patient of Grade II acne vulgaris.

Materials and Methods: It was a prospective interventional study with split face comparative study design. Each patient was received a pair of labeled tubes of medication – Right (Rt) side containing clindamycin 1% and left (Lt) side containing dapsone gel 5%. The assessment was done by calculating the change from baseline, after 4, 8, and 12 weeks of the total lesion count and both inflammatory and non-inflammatory lesions using repeated measures analysis of variance.

Results: A total of 40 patients were included in the study. Both inflammatory and non-inflammatory lesion count reduce significantly at the end of 4, 8, and 12 weeks on both side (P < 0.05). Mean reduction in total count of lesions after 12 weeks of therapy by dapsone 5% was 5.4 ± 5.05 (50.0%), while by clindamycin 1% gel was 5.0 ± 2.76 (50.5%).

Conclusion: Dapsone 5% gel monotherapy and clindamycin 1% gel monotherapy have almost equal efficacy when compared after 12 weeks of therapy, but dapsone 5% gel therapy is slightly better effect on inflammatory lesions than clindamycin 1% gel.

Key words: Grade II Acne Vulgaris; 1% Clindamycin; 5% Dapsone; Topical Therapy

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Richa Verma Articles by Preeti Yadav Articles by Mayur Chudhari Articles by Jayshree Patel Articles by Dipak Umrigar
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Verma R, Yadav P, Chudhari M, Patel J, Umrigar D. Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study. Natl J Physiol Pharm Pharmacol. 2022; 12(6): 817-822. doi:10.5455/njppp.2022.12.03100202221042022

Web Style

Verma R, Yadav P, Chudhari M, Patel J, Umrigar D. Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study. https://www.njppp.com/?mno=96704 [Access: March 14, 2024]. doi:10.5455/njppp.2022.12.03100202221042022

AMA (American Medical Association) Style

Verma R, Yadav P, Chudhari M, Patel J, Umrigar D. Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study. Natl J Physiol Pharm Pharmacol. 2022; 12(6): 817-822. doi:10.5455/njppp.2022.12.03100202221042022

Vancouver/ICMJE Style

Verma R, Yadav P, Chudhari M, Patel J, Umrigar D. Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study. Natl J Physiol Pharm Pharmacol. (2022), [cited March 14, 2024]; 12(6): 817-822. doi:10.5455/njppp.2022.12.03100202221042022

Harvard Style

Verma, R., Yadav, . P., Chudhari, . M., Patel, . J. & Umrigar, . D. (2022) Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study. Natl J Physiol Pharm Pharmacol, 12 (6), 817-822. doi:10.5455/njppp.2022.12.03100202221042022

Turabian Style

Verma, Richa, Preeti Yadav, Mayur Chudhari, Jayshree Patel, and Dipak Umrigar. 2022. Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (6), 817-822. doi:10.5455/njppp.2022.12.03100202221042022

Chicago Style

Verma, Richa, Preeti Yadav, Mayur Chudhari, Jayshree Patel, and Dipak Umrigar. "Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 817-822. doi:10.5455/njppp.2022.12.03100202221042022

MLA (The Modern Language Association) Style

Verma, Richa, Preeti Yadav, Mayur Chudhari, Jayshree Patel, and Dipak Umrigar. "Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study." National Journal of Physiology, Pharmacy and Pharmacology 12.6 (2022), 817-822. Print. doi:10.5455/njppp.2022.12.03100202221042022

APA (American Psychological Association) Style

Verma, R., Yadav, . P., Chudhari, . M., Patel, . J. & Umrigar, . D. (2022) Comparison of efficacy of two topical drug therapy of acne vulgaris – 1% clindamycin versus 5% dapsone: A split face comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (6), 817-822. doi:10.5455/njppp.2022.12.03100202221042022

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272